Citations

Clear

7552 citation(s) found for "Ku, Matthew".

Overview of ADNI MRI
Jack, Clifford R. , Arani, Arvin , Borowski, Bret, Crawford, Karen , DeCarli, Charles , Fletcher, Evan, Fox, Nick C. , Gunter, Jeffrey L. , Ittyerah, Ranjit, Harvey, Danielle , Jahanshad, Neda , Maillard, Pauline , Malone, Ian B., Reyes, Denise A., Thomas, David L. , Thompson, Paul M., Tosun, Duygu , Ward, Chadwick P., Weiner, Michael W., Initiative, Alzheimer's Disease Neuroimaging, DeCarli, Charles , Malone, Ian B. , Borowski, Bret J, Jack, Clifford R , Arani, Arvin , Fox, Nick C , Harvey, Danielle J , Tosun, Duygu , Maillard, Pauline , Cash, David M. , Das, Sandhitsu R. , Nir, Talia M. , Reid, Robert I. , Schwarz, Christopher G. , Senjem, Matthew L. , Thompson, Paul M. , Yushkevich, Paul A. , Initiative, Alzheimer's Disease Neuroimaging

Mayo Clinic

Alzheimer's & Dementia | September 11, 2024 | Volume: 20 | Issue: 10 | Pages: 7350-7360

10.1002/alz.14166 | PMID 39258539 Get It

Abstract The magnetic resonance imaging (MRI) Core has been operating since Alzheimer's Disease Neuroimaging Initiative's (ADNI) inception, providing 20 years of data including reliable, multi‐platform standardized protocols, carefully curated image data, and quantitative measures provided by expert investigators. The overarching purposes of the MRI Core include: (1) optimizing and standardizing MRI acquisition methods, which have been adopted by many multicenter studies and trials worldwide and (2) providing curated images and numeric summary values from relevant MRI sequences/contrasts to the scientific community. Over time, ADNI MRI has become increasingly complex. To remain technically current, the ADNI MRI protocol has changed substantially over the past two decades. The ADNI 4 protocol contains nine different imaging types (e.g., three dimensional [3D] T1‐weighted and fluid‐attenuated inversion recovery [FLAIR]). Our view is that the ADNI MRI data are a greatly underutilized resource. The purpose of this paper is to educate the scientific community on ADNI MRI methods and content to promote greater awareness, accessibility, and use. Highlights The MRI Core provides multi‐platform standardized protocols, carefully curated image data, and quantitative analysis by expert groups. The ADNI MRI protocol has undergone major changes over the past two decades to remain technically current. As of April 25, 2024, the following numbers of image series are available: 17,141 3D T1w; 6877 FLAIR; 3140 T2/PD; 6623 GRE; 3237 dMRI; 2846 ASL; 2968 TF‐fMRI; and 2861 HighResHippo (see Table 1 for abbreviations). As of April 25, 2024, the following numbers of quantitative analyses are available: FreeSurfer 10,997; BSI 6120; tensor based morphometry (TBM) and TBM‐SYN 12,019; WMH 9944; dMRI 1913; ASL 925; TF‐fMRI NFQ 2992; and medial temporal subregion volumes 2726 (see Table 4 for abbreviations). ADNI MRI is an underutilized resource that could be more useful to the research community.
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis
Abro, Brooj , Maurer, Matthew J. , Burack, Richard , Chapman, Jennifer R. , Cohen, Jonathon B. , Friedberg, Jonathan W. , Inghirami, Giorgio , Lossos, Izidore S. , Martin, Peter W., McDonnell, Timothy J. , Riska, Shaun M., Flowers, Christopher R. , Burack, W Richard , Cohen, Jonathon B , Inghirami, Giorgio , Link, Brian K , Lossos, Izidore S , Nastoupil, Loretta J , Vega, Francisco , Cerhan, James R , Feldman, Andrew L , Maurer, Matthew , Habermann, Thomas M. , Kahl, Brad S. , Larson, Melissa C. , Link, Brian K. , Martin, Peter, Nastoupil, Loretta J. , Syrbu, Sergei , Vega, Francisco , Vij, Kiran R , Cerhan, James R. , Jaye, David L. , Feldman, Andrew L.

Mayo Clinic

Blood | September 10, 2024 | Volume: 144 | Issue: 19 | Pages: 2063-2066

10.1182/blood.2024025681 | PMID 39255410 Get It

Abstract Recent introduction of 2 different lymphoma classifications has raised concerns about consistency in diagnosis, management, and clinical trial enrollment. Data from a large cohort reflecting real-world clinical practice suggest that differences between the classifications will affect <1% of non-Hodgkin lymphomas.
Digital behaviour change intervention for weight loss maintenance in adults with obesity: a feasibility pilot study of eCHANGE
Asbjørnsen, Rikke Aune , Børøsund, Elin , Hjelmesæth, Jøran , Smedsrød, Mirjam Lien , Ollivier, M. , Wentzel, Jobke , Clark, Matthew M. , Gemert‐Pijnen, Julia E.W.C. van , Nes, Lise Solberg , Solberg Nes, Lise , Børøsund, Elin , Ollivier, M.

Mayo Clinic

Behaviour & Information Technology | September 10, 2024 | Volume: 44 | Issue: 11 | Pages: 2577-2595

10.1080/0144929x.2024.2399299 Get It

High‐quality FLORET UTE imaging for clinical translation
Willmering, Matthew M. , Krishnamoorthy, Guruprasad , Rosenberg, Jens T. , Woods, Jason C. , Pipe, James G. , Robison, Ryan K.

Mayo Clinic

Magnetic Resonance in Medicine | September 2, 2024 | Volume: 93 | Issue: 1 | Pages: 276-288

10.1002/mrm.30277 | PMID 39219306 Get It

AbstractPurposeTo develop a robust 3D ultrashort‐TE (UTE) protocol that can reproducibly provide high‐quality images, assessed by the ability to yield clinically diagnostic images, and is suitable for clinical translation.Theory and MethodsBuilding on previous work, a UTE sampled with Fermat looped orthogonally encoded trajectories (FLORET) was chosen as a starting point due to its shorter, clinically reasonable scan times. Modifications to previous FLORET implementations included gradient waveform frequency limitations, a new trajectory ordering scheme, a balanced SSFP implementation, fast gradient spoiling, and full inline reconstruction. FLORET images were collected in phantoms and humans on multiple scanners and sites to demonstrate these improvements.ResultsThe updates to FLORET provided high‐quality images in phantom, musculoskeletal, and pulmonary applications. The gradient waveform modifications and new trajectory ordering scheme significantly reduced visible artifacts. Fast spoiling reduced acquisition time by 20%–28%. Across the various scanners and sites, the inline image quality was consistent and of diagnostic quality. Total image acquisition plus reconstruction time was less than 4 min for musculoskeletal and pulmonary applications with reconstructions taking less than 1 min.ConclusionRecently developed improvements for the FLORET sequence have enabled robust, high‐quality UTE acquisitions with short acquisition and reconstruction times. This enables clinical UTE imaging as demonstrated by the implementation of the sequence and acquisition on five MRI scanners, at three different sites, without the need for any additional system characterization or measurements.
Appropriate interpretation of TRBC1 ‐dim positive subsets in T‐cell immunophenotyping by flow cytometry
Weybright, Matthew J. , Otteson, Gregory E., Olteanu, Horatiu , Olteanu, Horatiu , Horna, Pedro , Shi, Min , Jevremović, Dragan

Mayo Clinic

Cytometry Part B: Clinical Cytometry | September 2, 2024 | Volume: 108 | Issue: 2 | Pages: 172-175

10.1002/cyto.b.22204 | PMID 39221577 Get It

Digital Otoscopy With Computer‐Aided Composite Image Generation: Impact on the Correct Diagnosis, Confidence, and Time
Çamalan, Seda , Langefeld, Carl D. , Zinnia, Amy , McKee, Brigham, Carlson, Matthew L. , Deep, Nicholas L. , Harris, Michael S. , Kaul, Vivian F. , Lindquist, Nathan R. , Mattingly, Jameson K. , Shah, Jay , Zhan, Kevin Y. , Harris, Michael S , Jan, Taha Adnan , Gürcan, Metin N. , Moberly, Aaron C.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | September 2, 2024 | Volume: 172 | Issue: 1 | Pages: 152-161

10.1002/ohn.965 | PMID 39221462 Get It

AbstractObjectiveThis study investigated the comparative performance of ear, nose, and throat (ENT) physicians in correctly detecting ear abnormalities when reviewing digital otoscopy imaging using 3 different visualization methods, including computer‐assisted composite images called “SelectStitch,” single video frame “Still” images, and video clips. The study also explored clinicians' diagnostic confidence levels and the time to make a diagnosis.Study DesignClinician diagnostic reader study.SettingOnline diagnostic survey of ENT physicians.MethodsNine ENT physicians reviewed digital otoscopy examinations from 86 ears with various diagnoses (normal, perforation, retraction, middle ear effusion, tympanosclerosis). Otoscopy examinations used artificial‐intelligence (AI)‐based computer‐aided composite image generation from a video clip (SelectStitch), manually selected best still frame from a video clip (Still), or the entire video clip. Statistical analyses included comparisons of ability to detect correct diagnosis, confidence levels, and diagnosis times.ResultsThe ENT physicians' ability to detect ear abnormalities (33.2%‐68.7%) varied depending on the pathologies. SelectStitch and Still images were not statistically different in detecting abnormalities (P > .50), but both were different from Video (P < .01). However, the performance improvement observed with Videos came at the cost of significantly longer time to determining the diagnosis. The level of confidence in the diagnosis was positively associated with correct diagnoses, but varied by particular pathology.ConclusionThis study explores the potential of computer‐assisted techniques like SelectStitch in enhancing otoscopic diagnoses and time‐saving, which could benefit telemedicine settings. Comparable performance between computer‐generated and manually selected images suggests the potential of AI algorithms for otoscopy applications.
Life‐threatening hemorrhage as defined by the critical administration threshold in nontraumatic critical bleeding: A descriptive observational study
Matzek, Luke J. , Hanson, Andrew C. , Schulte, Phillip J. , Cureton, Kimberly D., Kor, Daryl J. , Warner, Matthew A. , Warner, Matthew A

Mayo Clinic

Transfusion | August 30, 2024 | Volume: 64 | Issue: 10 | Pages: 1841-1850

10.1111/trf.17996 | PMID 39210684 Get It

AbstractBackgroundEvaluations of critical bleeding and massive transfusion have focused on traumatic hemorrhage. However, most critical bleeding in hospitalized patients occurs outside trauma. The purpose of this study was to provide an in‐depth description examining the critical administration threshold (CAT; ≥3 units red blood cells (RBCs) in a 1‐h period) occurrences in nontraumatic hemorrhage. This will assist in establishing the framework for future investigations in nontraumatic hemorrhage.MethodsThis is an observational cohort study of adults experiencing critical bleeding defined as being CAT+ during hospitalization from 2016 to 2021 at a single academic institution. A CAT episode started with administration of the first qualifying RBC unit and ended at the time of completion of the last allogeneic unit prior to a ≥4‐h gap without subsequent transfusion. The primary goal was to describe demographic, clinical and transfusion characteristics of participants with nontraumatic critical bleeding.Results2433 patients suffered critical bleeding, most often occurring in the operating room (71.1%) followed by the intensive care unit (20.8%). 57% occurred on the initial day of hospitalization, with a median duration of 138 (36, 303) minutes. The median number of RBCs transfused during the episode was 5 (4, 8), with median total allogeneic units of 9 (4, 9). Hospital mortality was 19.2%. The most common cause of death was multi‐organ failure (50.3%), however death within 24 h was due to exsanguination (72.7%).DiscussionThe critical administration threshold may be employed to identify critical bleeding in non‐trauma settings of life‐threatening hemorrhage, with a mortality rate of approximately 20%.
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting
Kottschade, Lisa A. , Montane, Heather N. , Tan, Winston, Dronca, Roxana , Seetharam, ­Mahesh , Chen, Ruqin , Block, Matthew S. , Stoff, Ronen, Dronca, Roxana S., Stoff, Ronen , Markovic, Svetomir N. , McWilliams, Robert R. , Dimou, Anastasios , Dudek, Arkadiusz Z. , Tan, Winston

Mayo Clinic

Melanoma Research | August 29, 2024 | Volume: 34 | Issue: 6 | Pages: 510-518

10.1097/cmr.0000000000000997 | PMID 39207855 Get It

Melanoma is the deadliest form of skin cancer. The median age at diagnosis is 66. While most patients are treated with immunotherapy, the use of targeted therapy is a valid alternative for patients whose tumors harbor a BRAF or c-KIT driver mutation. These agents, while effective, come with a variety of side effects which limit their use, especially in older patients. We sought to assess the efficacy and toxicity of these agents in older melanoma patients. Melanoma patients over 65 treated with BRAF/MEK or c-KIT inhibitors were retrospectively identified, and their data were analyzed for treatment efficacy and toxicity. All data were compared using the Chi-square test for categorical comparisons and the Kruskal–Wallis method for median comparisons. One hundred and sixteen patients were identified. One hundred and six patients were treated with BRAF/MEK inhibitors. The assessed response rate (RR) was 83% and was comparable across different subgroups, including advanced line patients and those with a more aggressive disease. The median progression free survival (PFS) was 7.9 months, and the median overall survival (OS) was 15.7 months. Twenty-seven percent experienced grade 3–4 toxicity leading to a 24% treatment discontinuation rate. Another 10 patients were treated with the c-KIT inhibitor imatinib, for whom the assessed RR was 55%. The median PFS was 4.3 months, and the median OS was 22.6 months. Forty percent needed dose reductions, yet none had to stop treatment due to adverse effects. The use of targeted therapy in older patients is effective yet challenging due to toxicity. Deploying mitigation strategies can help maximizing their usefulness.
Epidemiology of cardiogenic shock using the Shock Academic Research Consortium (SHARC) consensus definitions
Berg, David D. , Patel, Siddharth M. , Alfonso, Carlos E., Alviar, Carlos L. , Baird-Zars, Vivian M., Barsness, Gregory W. , Bennett, Courtney , Gidwani, Umesh , Goldfarb, Michael , Katz, Jason N. , Menon, Venu , Miller, Patrick, Newby, L. Kristin , Papolos, Alexander , Park, Jeong‐Gun , Pierce, Matthew J, Proudfoot, Alastair , Sridharan, Lakshmi , Thompson, Andrea D. , Goldfarb, Michael , Pierce, Matthew , Menon, Venu , Park, Jeong-Gun , van Diepen, Sean , Goldfarb, Michael , Goldfarb, Michael , Berg, David , Thompson, Andrea , Patel, Siddharth M , Pierce, Matthew J , Proudfoot, Alastair G , Bohula, Erin A. , Barnett, Christopher F. , Chaudhry, Sunit‐Preet , Fordyce, Christopher B. , Ghafghazi, Shahab , Miller, P Elliott, Sinha, Shashank S , Diepen, Sean van , Morrow, David A.

Mayo Clinic

European Heart Journal: Acute Cardiovascular Care | August 29, 2024 | Volume: 13 | Issue: 10 | Pages: 709-714

10.1093/ehjacc/zuae098 | PMID 39208447 Get It

Abstract Aims The Shock Academic Research Consortium (SHARC) recently proposed pragmatic consensus definitions to standardize classification of cardiogenic shock (CS) in registries and clinical trials. We aimed to describe contemporary CS epidemiology using the SHARC definitions in a cardiac intensive care unit (CICU) population. Methods and results The Critical Care Cardiology Trials Network (CCCTN) is a multinational research network of advanced CICUs coordinated by the TIMI Study Group (Boston, MA). Cardiogenic shock was defined as a cardiac disorder resulting in SBP &lt; 90 mmHg for ≥30 min [or the need for vasopressors, inotropes, or mechanical circulatory support (MCS) to maintain SBP ≥ 90 mmHg] with evidence of hypoperfusion. Primary aetiologic categories included acute myocardial infarction-related CS (AMI-CS), heart failure-related CS (HF-CS), and non-myocardial (secondary) CS. Post-cardiotomy CS was not included. Heart failure-related CS was further subcategorized as de novo vs. acute-on-chronic HF-CS. Patients with both cardiogenic and non-cardiogenic components of shock were classified separately as mixed CS. Of 8974 patients meeting shock criteria (2017–23), 65% had isolated CS and 17% had mixed shock. Among patients with CS (n = 5869), 27% had AMI-CS (65% STEMI), 59% HF-CS (72% acute-on-chronic, 28% de novo), and 14% secondary CS. Patients with AMI-CS and de novo HF-CS were most likely to have had concomitant cardiac arrest (P &lt; 0.001). Patients with AMI-CS and mixed CS were most likely to present in more severe shock stages (SCAI D or E; P &lt; 0.001). Temporary MCS use was highest in AMI-CS (59%). In-hospital mortality was highest in mixed CS (48%), followed by AMI-CS (41%), similar in de novo HF-CS (31%) and secondary CS (31%), and lowest in acute-on-chronic HF-CS (25%; P &lt; 0.001). Conclusion SHARC consensus definitions for CS classification can be pragmatically applied in contemporary registries and reveal discrete subpopulations of CS with distinct phenotypes and outcomes that may be relevant to clinical practice and future research.